Lymphedema: Difference between revisions

From Citizendium
Jump to navigation Jump to search
imported>Howard C. Berkowitz
No edit summary
imported>Howard C. Berkowitz
No edit summary
Line 2: Line 2:
{{TOC|right}}
{{TOC|right}}
In [[medicine]], '''lymphedema''' exhibits as fluid retention due to damage to, or dysfunction of the [[lymphatic system]]. There may be multiple comorbid causes of fluid retention, such as metabolic disturbances.
In [[medicine]], '''lymphedema''' exhibits as fluid retention due to damage to, or dysfunction of the [[lymphatic system]]. There may be multiple comorbid causes of fluid retention, such as metabolic disturbances.
==Etiology==
Lymphedema may be primary, with a genetic etiology, or secondary, as a result of another disorder or physical damage. The secondary forms are probably more common.
===Secondary lymphedema===
===Primary lymphedema===
[[Lymphedema]] may have a genetic cause.<ref name=pmid18519967>{{citation
|journal = Ann N Y Acad Sci | year =  2008| volume = 1131 | pages = 140-6.
| title= Phenotypic characterization of primary lymphedema
| author = Connell F, Brice G, Mortimer P.
| url = http://www.ncbi.nlm.nih.gov/pubmed/18519967?log$=activity
| PMID = 18519967
}}</ref> Several types have been reported in the literature. They vary in in age of onset, site of edema, associated features, inheritance patterns, and underlying genetic cause. Determining the representative phenotype for different types of genetically determined primary lymphedema has been successfully achieved with Milroy's disease and the lymphedema-distichiasis syndrome.  Phenotype characterization facilitates the identification of causative genes, as has been demonstrated with VEGFR3 and FOXC2, in [[#Milroy's disease|Milroy's disease]] and lymphedema-distichiasis respectively.
Using transgenic and gene transfer techniques, the defects have been produced in mice, giving "initial clues to the development of a biologically based therapy for primary lymphedema. Of more importance from a public health perspective is the fact that manipulation of this pathway may lead to effective therapies for the more prevalent forms of secondary lymphedema."<ref name=Ferrell2002>{{citation
|  journal = Ann N Y Acad Sci | date = 2002 Dec| volume = 979 | pages = 39-51; discussion 76-9
| title = Research perspectives in inherited lymphatic disease.
| author = Ferrell RE
| url =http://www.ncbi.nlm.nih.gov/pubmed/12543715?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_Discovery_RA&linkpos=4&log$=relatedreviews&logdbfrom=pubmed
| PMID = 12543715
}}</ref> The known mutations leading to lymphatic phenotypes, however, explain fewer than half the cases of lymphedema.<ref name=>{{citation
| journal =  Ann N Y Acad Sci
| year = 2008|volume = 1131| pages = 134-9
| title = Research perspectives in inherited lymphatic disease: an update.
| author = Ferrell RE, Finegold DN
| url = http://www.ncbi.nlm.nih.gov/pubmed/18519966?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_Discovery_RA&linkpos=1&log$=relatedreviews&logdbfrom=pubmed
| PMID = 18519966}}</ref> Nevertheless, there are research directions for treatment, based on lymphangiogenesis, the triggering of new lymphatic system growth.<ref name=Nakamura2008>{{citation
| journal = Lymphat Res Biol | date = 2008| volume = 6 | issue = (3-4) | pages = 181-9
| title = Molecular targets for therapeutic lymphangiogenesis in lymphatic dysfunction and disease.
| author = Nakamura K, Rockson SG | pmid = 19093791
| url = http://www.ncbi.nlm.nih.gov/pubmed/19093791?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_Discovery_RA&linkpos=4&log$=relatedreviews&logdbfrom=pubmed}}</ref>
Malformation would mean either few lymph vessels or they may be in excess. Both would cause a hindrance to the smooth working of the lymphatic system resulting in the pooling of fluids.
====Milroy's disease====
This is the first type of hereditary lymphedema caused as a result of inheriting a certain gene at birth. The condition is generally apparent in the legs, usually in one leg, but in some cases, it may be seen in both legs. Doctors diagnose the condition by studying the swelling present in the legs right from birth. Deeper enquiries may result in finding a family history of such type of swelling. In order to confirm the diagnosis, tests may be conducted. A dye is injected into the leg which is traced by a computer to find out where the blockages are present. Milroy's Disease is treated with decongestive therapy. Patients may experience complications like fibrosis in the limb tissues, lymphangitis or cellulitis.
====Lymphedema-distichiasis syndrome====
Caused by  mutations in the FOXC2-gene, the lymphedema-distichiasis syndrome involves malformations of both the lymphatic and vascular systems. It "is characterized by late childhood or pubertal onset lymphedema of the limbs and distichiasis (double row of eyelashes). While the latter is the most common expression of LD, venous insufficiency occurs in half of the patients. Other associations have been reported, including congenital heart disease, ptosis, cleft lip/palate and spinal extradural cysts"<ref>{{citation
|  journal = Int J Dermatol | date =  2008 Nov | volume = 47 | issue = Suppl 1 | pages = 52-5
| title  = Lymphedema-distichiasis syndrome: a distinct type of primary lymphedema caused by mutations in the FOXC2 gene.
| author = Vreeburg M, Heitink MV, Damstra RJ, Moog U, van Geel M, van Steensel MA
| pmid = 18986489
| url = http://www.ncbi.nlm.nih.gov/pubmed/18986489?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_Discovery_RA&linkpos=1&log$=relatedarticles&logdbfrom=pubmed
}}</ref>
====Meige's Disease====
Also known as Lymphedema Praecox Meige or Hereditary Lymphedema Type II), this condition of lymphedema shows up during the teenage years and is quite a common variety of primary lymphedema. The initial indication of the genetic disorder is [[cleft palate]].<ref name=Figueroa1983>{{citation
| journal =  Cleft Palate J. | date = 1983 Apr | volume = 20 | issue = 2| pages =151-7
| title = Meige disease (familial lymphedema praecox) and cleft palate: report of a family and review of the literature
| author = Figueroa AA, Pruzansky S, Rollnick BR
| PMID = 6342849
| url = http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Search&tool=UTHSCSAplugins&otool=uthscsalib&db=pubmed&term=Lymphedema%20Praecox%20Meige}}</ref>
...and the first signs of the condition are a swelling below the waist, red patches on the skin, inflammation and discomfort. Again, this hereditary lymphedema is diagnosed by observing the swelling and the family history confirming the verdict. Some other hints could be yellow nail syndrome or pulmonary hypertension. As with all other lymphedema treatments, decongestive therapy is the ideal choice here as well. Treatment must be started at the initial phase of the condition.
====Lymphedema Tarda====
Also known as  Hereditary Lymphedema Type III /Delayed Onset Lymphedema, as the name suggests, this condition becomes apparent only after the age of thirty five. Swelling may be present in either one or both the legs. Women are more at risk for this ailment than men. Very often, family history of a similar swelling is observed. 


==Diagnosis==
==Diagnosis==
Lymphedema should be distinguished from [[edema]], [[myxedema]], and [[lipedema]].<ref name="pmid8479476">{{cite journal |author=Loughlin V |title=Massive obesity simulating lymphedema |journal=N. Engl. J. Med. |volume=328 |issue=20 |pages=1496 |year=1993 |month=May |pmid=8479476 |doi= |url=http://content.nejm.org/cgi/content/full/328/20/1496 |issn=}}</ref> Lipedema is more likely to spare the dorsum of the foot.
Lymphedema should be distinguished from [[edema]], [[myxedema]], and [[lipedema]].<ref name="pmid8479476">{{cite journal |author=Loughlin V |title=Massive obesity simulating lymphedema |journal=N. Engl. J. Med. |volume=328 |issue=20 |pages=1496 |year=1993 |month=May |pmid=8479476 |url=http://content.nejm.org/cgi/content/full/328/20/1496 |issn=}}</ref> Lipedema is more likely to spare the dorsum of the foot.


It is possible, however, to have comorbid edema and lymphedema. For example, a vasodilator used to treat [[hypertension]] can cause edema in a patient with cardiac disease. If that patient has had the lymphatics of the lower leg damaged by stripping the [[saphenous vein]] for use as an arterial graft, that damage can cause lymphedema to coexist with edema.
It is possible, however, to have comorbid edema and lymphedema. For example, a vasodilator used to treat [[hypertension]] can cause edema in a patient with cardiac disease. If that patient has had the lymphatics of the lower leg damaged by stripping the [[saphenous vein]] for use as an arterial graft, that damage can cause lymphedema to coexist with edema.
Line 16: Line 70:
==Treatment==
==Treatment==
Multilayer compression bandaging for 2-3 weeks followed by hosiery may reduce the size of limbs with lymphedema.<ref name="pmid10870068">{{cite journal |author=Badger CM, Peacock JL, Mortimer PS |title=A randomized, controlled, parallel-group clinical trial comparing multilayer bandaging followed by hosiery versus hosiery alone in the treatment of patients with lymphedema of the limb |journal=Cancer |volume=88 |issue=12 |pages=2832–7 |year=2000 |month=June |pmid=10870068 |doi= |url=http://dx.doi.org/10.1002/1097-0142(20000615)88:12<2832::AID-CNCR24>3.0.CO;2-U |issn=}}</ref>
Multilayer compression bandaging for 2-3 weeks followed by hosiery may reduce the size of limbs with lymphedema.<ref name="pmid10870068">{{cite journal |author=Badger CM, Peacock JL, Mortimer PS |title=A randomized, controlled, parallel-group clinical trial comparing multilayer bandaging followed by hosiery versus hosiery alone in the treatment of patients with lymphedema of the limb |journal=Cancer |volume=88 |issue=12 |pages=2832–7 |year=2000 |month=June |pmid=10870068 |doi= |url=http://dx.doi.org/10.1002/1097-0142(20000615)88:12<2832::AID-CNCR24>3.0.CO;2-U |issn=}}</ref>
==References==
==References==
<references/>
{{reflist|2}}

Revision as of 13:23, 5 September 2009

This article is developing and not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and subject to a disclaimer.

In medicine, lymphedema exhibits as fluid retention due to damage to, or dysfunction of the lymphatic system. There may be multiple comorbid causes of fluid retention, such as metabolic disturbances.

Etiology

Lymphedema may be primary, with a genetic etiology, or secondary, as a result of another disorder or physical damage. The secondary forms are probably more common.

Secondary lymphedema

Primary lymphedema

Lymphedema may have a genetic cause.[1] Several types have been reported in the literature. They vary in in age of onset, site of edema, associated features, inheritance patterns, and underlying genetic cause. Determining the representative phenotype for different types of genetically determined primary lymphedema has been successfully achieved with Milroy's disease and the lymphedema-distichiasis syndrome. Phenotype characterization facilitates the identification of causative genes, as has been demonstrated with VEGFR3 and FOXC2, in Milroy's disease and lymphedema-distichiasis respectively.

Using transgenic and gene transfer techniques, the defects have been produced in mice, giving "initial clues to the development of a biologically based therapy for primary lymphedema. Of more importance from a public health perspective is the fact that manipulation of this pathway may lead to effective therapies for the more prevalent forms of secondary lymphedema."[2] The known mutations leading to lymphatic phenotypes, however, explain fewer than half the cases of lymphedema.[3] Nevertheless, there are research directions for treatment, based on lymphangiogenesis, the triggering of new lymphatic system growth.[4]


Malformation would mean either few lymph vessels or they may be in excess. Both would cause a hindrance to the smooth working of the lymphatic system resulting in the pooling of fluids.

Milroy's disease

This is the first type of hereditary lymphedema caused as a result of inheriting a certain gene at birth. The condition is generally apparent in the legs, usually in one leg, but in some cases, it may be seen in both legs. Doctors diagnose the condition by studying the swelling present in the legs right from birth. Deeper enquiries may result in finding a family history of such type of swelling. In order to confirm the diagnosis, tests may be conducted. A dye is injected into the leg which is traced by a computer to find out where the blockages are present. Milroy's Disease is treated with decongestive therapy. Patients may experience complications like fibrosis in the limb tissues, lymphangitis or cellulitis.

Lymphedema-distichiasis syndrome

Caused by mutations in the FOXC2-gene, the lymphedema-distichiasis syndrome involves malformations of both the lymphatic and vascular systems. It "is characterized by late childhood or pubertal onset lymphedema of the limbs and distichiasis (double row of eyelashes). While the latter is the most common expression of LD, venous insufficiency occurs in half of the patients. Other associations have been reported, including congenital heart disease, ptosis, cleft lip/palate and spinal extradural cysts"[5]

Meige's Disease

Also known as Lymphedema Praecox Meige or Hereditary Lymphedema Type II), this condition of lymphedema shows up during the teenage years and is quite a common variety of primary lymphedema. The initial indication of the genetic disorder is cleft palate.[6]

...and the first signs of the condition are a swelling below the waist, red patches on the skin, inflammation and discomfort. Again, this hereditary lymphedema is diagnosed by observing the swelling and the family history confirming the verdict. Some other hints could be yellow nail syndrome or pulmonary hypertension. As with all other lymphedema treatments, decongestive therapy is the ideal choice here as well. Treatment must be started at the initial phase of the condition.

Lymphedema Tarda

Also known as Hereditary Lymphedema Type III /Delayed Onset Lymphedema, as the name suggests, this condition becomes apparent only after the age of thirty five. Swelling may be present in either one or both the legs. Women are more at risk for this ailment than men. Very often, family history of a similar swelling is observed.

Diagnosis

Lymphedema should be distinguished from edema, myxedema, and lipedema.[7] Lipedema is more likely to spare the dorsum of the foot.

It is possible, however, to have comorbid edema and lymphedema. For example, a vasodilator used to treat hypertension can cause edema in a patient with cardiac disease. If that patient has had the lymphatics of the lower leg damaged by stripping the saphenous vein for use as an arterial graft, that damage can cause lymphedema to coexist with edema.

Physical examination

On physical examination, fast recovery of pitting is associated with lower serum albumin levels.[8] Fast recovery within 2-3 seconds, is more sensitive than specific at detecting hypoalbuminemia. Presumably this is related to the viscosity of the interstitial fluid thus hypoalbuminemic interstitial fluid can reform more quickly.[8]

Imaging

Oil contrast lymphography may be used for diagnosis. Whole-body lymphangioscintigraphy may help in the diagnosis.[9] Magnetic resonance imaging may help in the diagnosis.[10]

Treatment

Multilayer compression bandaging for 2-3 weeks followed by hosiery may reduce the size of limbs with lymphedema.[11]

References

  1. Connell F, Brice G, Mortimer P. (2008), "Phenotypic characterization of primary lymphedema", Ann N Y Acad Sci 1131: 140-6.
  2. Ferrell RE (2002 Dec), "Research perspectives in inherited lymphatic disease.", Ann N Y Acad Sci 979: 39-51; discussion 76-9
  3. Ferrell RE, Finegold DN (2008), "Research perspectives in inherited lymphatic disease: an update.", Ann N Y Acad Sci 1131: 134-9
  4. Nakamura K, Rockson SG (2008), "Molecular targets for therapeutic lymphangiogenesis in lymphatic dysfunction and disease.", Lymphat Res Biol 6 ((3-4)): 181-9
  5. Vreeburg M, Heitink MV, Damstra RJ, Moog U, van Geel M, van Steensel MA (2008 Nov), "Lymphedema-distichiasis syndrome: a distinct type of primary lymphedema caused by mutations in the FOXC2 gene.", Int J Dermatol 47 (Suppl 1): 52-5
  6. Figueroa AA, Pruzansky S, Rollnick BR (1983 Apr), "Meige disease (familial lymphedema praecox) and cleft palate: report of a family and review of the literature", Cleft Palate J. 20 (2): 151-7
  7. Loughlin V (May 1993). "Massive obesity simulating lymphedema". N. Engl. J. Med. 328 (20): 1496. PMID 8479476.
  8. 8.0 8.1 Henry JA, Altmann P (April 1978). "Assessment of hypoproteinaemic oedema: a simple physical sign". British medical journal 1 (6117): 890–1. PMID 638510. PMC 1603695[e] PubMed Central
  9. McNeill GC, Witte MH, Witte CL, et al. (August 1989). "Whole-body lymphangioscintigraphy: preferred method for initial assessment of the peripheral lymphatic system". Radiology 172 (2): 495–502. PMID 2748831[e]
  10. Case TC, Witte CL, Witte MH, Unger EC, Williams WH (1992). "Magnetic resonance imaging in human lymphedema: comparison with lymphangioscintigraphy". Magn Reson Imaging 10 (4): 549–58. PMID 1501525[e]
  11. Badger CM, Peacock JL, Mortimer PS (June 2000). <2832::AID-CNCR24>3.0.CO;2-U "A randomized, controlled, parallel-group clinical trial comparing multilayer bandaging followed by hosiery versus hosiery alone in the treatment of patients with lymphedema of the limb". Cancer 88 (12): 2832–7. PMID 10870068[e]